“I really got good support from your end in conducting visit, updating EDC and timely resolving the queries and yes during my on site and telephonic monitoring visits all these days and thanks for this.”
- CRACRA
“I fall short of words, I cannot emphasize how much I enjoyed working with you, my experience of this association of 2.5+ years !! R1 has planted a seed of clinical research in Sri Lanka few years back, you all have watered it, its growing rapidly and would soon be a gigantic tree in the near future.”
- Sachin S MangalvedhekarSachin S Mangalvedhekar
Senior Manager-Clinical Project Management ; SiroClinPharm
“Yesterday the Sri Lankan team has randomized their 200th Patient…….CONGRATULATIONS to the entire team. All possible because of your persistent hard work, and dedication of the site team to achieve this.”
- Sanofi Senior Project ManagerSanofi Senior Project Manager
“I am delighted with the DEN-301 study progress, as you are aware, it’s a busy time with second vaccinations and surveillance but I am very pleased with the progress reports I receive from the team in relation to Sri Lanka.”
- Karen McCarthyKaren McCarthy
Sr.Director – Project Management; Infectious diseases
“I am finally back home; i.e. in the office, after the meeting in Hamburg – Germany where I went directly from Colombo. I am still under a big impression of all I saw and experienced in Sri Lanka and I am looking forward to work together with all of you – RO colleagues on this and other studies in the future. I am sure that together we can achieve a lot of success.”
- Branka DuvnjakBranka Duvnjak
Head of site management, Ergomed
“This is a historical day for all of us. Thanks for all your guidance and support in making this happen. I know this is possible through a wonderful team work. Please convey my heartfelt thanks to all. I look forward to your continued support as we move ahead in this journey.”
- Anirban Roy ChowdhuryAnirban Roy Chowdhury
Senior Director, Global Clinical Trial Operations at MSD Pharmaceuticals
“Sri Lanka has hit their country target of 2,100 subjects last Saturday. On behalf of Takeda Vaccines, we would like to congratulate you and your team for reaching your target this early. This is a big achievement, your country is the second globally to reach their target. Thank you very much for all the efforts put into this !”
- Dr. Yanee and DebbieDr. Yanee and Debbie
Medical Monitors
Takeda Pharmaceuticals
“Congratulations to this amazing team for their OUTSTANDING performance !! Your hard work and persistence is greatly appreciated. Above all, your patient centric approach and commitment to quality and ethics is exemplary. I wish you all the very best. Keep up the good work.”
- Mubarak NaqviMubarak Naqvi,
Senior Director, Medical & Regulatory Affairs, Sanofi
“Looking forward to continuing to work with you all.”
- Prof. Anushka PatelProf. Anushka Patel
Chief Scientist, The George Institute for Global Health
Professor of Medicine, UNSW Sydney
Cardiologist, Royal Prince Alfred Hospital